GlassScriptPhysician profile
Rania Ibrahim
NPI 1912130667
$2,267.04
in general payments reported to CMS, 2019-2025
27 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $245 · 2021: $302 · 2022: $587 · 2023: $386 · 2024: $279 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.43 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $596.74 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $192.89 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $162.06 | 2022 | |
| Janssen Pharmaceuticals, INC | $124.40 | 2020 | |
| Exeltis, USA INC. | $113.12 | 2021-2025 | Slynd, Solosec |
| Astellas Pharma US INC | $91.96 | 2023-2025 | Veozah |
| Vertical Pharmaceuticals, LLC | $83.60 | 2019-2020 | |
| Myovant Sciences INC. | $82.83 | 2022 | |
| Lupin INC. | $72.25 | 2019-2021 | |
| Pfizer INC. | $67.89 | 2023-2024 | |
| Ascend Therapeutics US, LLC | $65.60 | 2019-2022 | |
| Exact Sciences Corporation | $64.66 | 2023-2025 | Cologuard Collection Kit |
| Organon LLC | $64.59 | 2021-2023 | Nexplanon |
| Hologic Sales and Service, LLC | $60.08 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Millicent US INC | $55.81 | 2019-2024 | Intrarosa |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $55.61 | 2022-2024 | Phexxi |
| Avion Pharmaceuticals | $55.45 | 2020-2023 | Balcoltra |
| Coopersurgical, INC. | $53.93 | 2021-2024 | Paragard T 380a |
| Aspira Women'S Health INC | $36.54 | 2022-2024 | Ova1 |
| Acessa Health INC. | $23.54 | 2019 | |
| Therapeuticsmd, INC. | $22.93 | 2019 | |
| Allergan, INC. | $22.65 | 2019-2020 | |
| Urovant Sciences INC | $22.17 | 2022 | |
| Daiichi Sankyo INC. | $21.98 | 2019 | |
| Gynesonics, INC. | $20.97 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $18.77 | 2019 | |
| Duchesnay USA Incorporated | $14.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rania Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.